| Citation: | CHEN Shixuan, CHEN Zhenzhen, CHEN Wenci, JI Jing. Causal association between iron homeostasis and functional outcome after ischemic stroke: a two-sample univariate and multivariate Mendelian randomization study[J]. Chinese Journal of General Practice, 2025, 23(12): 2017-2021. doi: 10.16766/j.cnki.issn.1674-4152.004281 |
| [1] |
王陇德, 彭斌, 张鸿祺, 等. 《中国脑卒中防治报告2020》概要[J]. 中国脑血管病杂志, 2022, 19(2): 136-144.
WANG L D, PENG B, ZHANG H Q, et al. Brief report on stroke prevention and treatment in China, 2020[J]. Chin J Cerebrovasc Dis, 2022, 19(2): 136-144.
|
| [2] |
HAN J, ZHANG J, YAO X, et al. Mechanism of HDAC1 regulating iron overload-induced neuronal oxidative damage after cerebral hemorrhage[J]. Mol Neurobiol, 2024, 61(10): 7549-7566. doi: 10.1007/s12035-024-04000-2
|
| [3] |
SAKIB A A, MIAH M, ALAM M K, et al. Relation of serum ferritin level with severity of neurological disability among patients with acute ischemic stroke[J]. Mymensingh Med J, 2024, 33(4): 973-979.
|
| [4] |
陈娟, 陈世宣, 王丰, 等. 血清铁相关指标与脑卒中后认知障碍风险的相关性[J]. 中华全科医学, 2024, 22(11): 1876-1879. doi: 10.16766/j.cnki.issn.1674-4152.003754
CHEN J, CHEN S X, WANG F, et al. Correlation analysis between serum iron-related indicators and the risk of post-stroke cognitive impairment in stroke patients[J]. Chinese Journal of General Practice, 2024, 22(11): 1876-1879. doi: 10.16766/j.cnki.issn.1674-4152.003754
|
| [5] |
YEH S J, CHEN C H, LIN Y H, et al. Association of ferroptosis with severity and outcomes in acute ischemic stroke patients undergoing endovascular thrombectomy: a case-control study[J]. Mol Neurobiol, 2023, 60(10): 5902-5914. doi: 10.1007/s12035-023-03448-y
|
| [6] |
WU Q, WEI C, LIU J, et al. Effects of hyperferritinemia on functional outcome in acute ischemic stroke patients with admission hyperglycemia[J]. Cerebrovasc Dis, 2023, 52(5): 511-518. doi: 10.1159/000527860
|
| [7] |
RICHMOND R C, DAVEY S G. Mendelian randomization: concepts and scope[J]. Cold Spring Harb Perspect Med, 2022, 12(1): a40501. DOI: 10.1101/cshperspect.a040501.
|
| [8] |
BELL S, RIGAS A S, MAGNUSSON M K, et al. A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis[J]. Commun Biol, 2021, 4(1): 156. DOI: 10.1038/s42003-020-01575-z.
|
| [9] |
LIU Y, BASTY N, WHITCHER B, et al. Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning[J]. Elife, 2021, 10(6): e65554. DOI: 10.7554/eLife.65554.
|
| [10] |
SODERHOLM M, PEDERSEN A, LORENTZEN E, et al. Genome-wide association meta-analysis of functional outcome after ischemic stroke[J]. Neurology, 2019, 92(12): e1271-e1283.
|
| [11] |
CHEN S, CHEN Z, XU Q, et al. Dual effects of serum urate on stroke risk and prognosis: insights from Mendelian randomization[J]. Front Neurol, 2024, 15: 1359292. DOI: 10.3389/fneur.2024.1359292.
|
| [12] |
TIAN Y, TIAN Y, YUAN Z, et al. Iron metabolism in aging and age-related diseases[J]. Int J Mol Sci, 2022, 23(7): 3612. DOI: 10.3390/ijms23073612.
|
| [13] |
FAN X, LI A, YAN Z, et al. From iron metabolism to ferroptosis: pathologic changes in coronary heart disease[J]. Oxid Med Cell Longev, 2022, 2022(8): 6291889. DOI: 10.1155/2022/6291889.
|
| [14] |
HU H, CHEN Y, JING L, et al. The link between ferroptosis and cardiovascular diseases: a novel target for treatment[J]. Front Cardiovasc Med, 2021, 8(7): 710963. DOI: 10.3389/fcvm.2021.710963.
|
| [15] |
LEVI S, RIPAMONTI M, MORO A S, et al. Iron imbalance in neurodegeneration[J]. Mol Psychiatry, 2024, 29(4): 1139-1152. doi: 10.1038/s41380-023-02399-z
|
| [16] |
BU Z Q, YU H Y, WANG J, et al. Emerging role of ferroptosis in the pathogenesis of ischemic stroke: a new therapeutic target?[J]. ASN Neuro, 2021, 13: 523058879. DOI: 10.1177/17590914211037505.
|
| [17] |
MAO H, DOU W, WANG X, et al. Iron deposition in fray matter nuclei of patients with intracranial artery stenosis: a quantitative susceptibility mapping study[J]. Front Neurol, 2021, 12: 785822. DOI: 10.3389/fneur.2021.785822.
|
| [18] |
KATAIKE V M, DESMOND P M, STEWARD C, et al. Iron changes within infarct tissue in ischemic stroke patients after successful reperfusion quantified using QSM[J]. Neuroradiology, 2024, 66(12): 2233-2242. doi: 10.1007/s00234-024-03444-6
|
| [19] |
JIN Y, HUANG Y H, CHEN Y P, et al. Combined effect of cortical superficial siderosis and cerebral microbleed on short-term and long-term outcomes after intracerebral haemorrhage[J]. Stroke Vasc Neurol, 2024, 9(4): 429-438. doi: 10.1136/svn-2023-002439
|
| [20] |
RAJENDRAN S R, PERIYASAMY S, MANJULADEVI M T, et al. Evaluation of serum ferritin as a prognostic marker in acute hemorrhagic stroke[J]. J Neurosci Rural Pract, 2020, 11(1): 72-77.
|
| [21] |
SAKIB A A, MIAH M, ALAM M K, et al. Relation of serum ferritin level with severity of neurological disability among patients with acute ischemic stroke[J]. Mymensingh Med J, 2024, 33(4): 973-979.
|
| [22] |
HE Q, WANG W, XU D, et al. Causal association of iron status with functional outcome after ischemic stroke[J]. Stroke, 2024, 55(2): 423-431. doi: 10.1161/STROKEAHA.123.044930
|
| [23] |
DU B, DENG Z, CHEN K, et al. Iron promotes both ferroptosis and necroptosis in the early stage of reperfusion in ischemic stroke[J]. Genes Dis, 2024, 11(6): 101262. DOI: 10.1016/j.gendis.2024.101262.
|
| [24] |
MILLAN M, DEGREGORIO-ROCASOLANO N, PEREZ D L O N, et al. Targeting pro-oxidant iron with deferoxamine as a treatment for ischemic stroke: safety and optimal dose selection in a randomized clinical trial[J]. Antioxidants(Basel), 2021, 10(8): 1270. DOI: 10.3390/antiox10081270.
|
| [25] |
DELGADO-MARTIN S, MARTINEZ-RUIZ A. The role of ferroptosis as a regulator of oxidative stress in the pathogenesis of ischemic stroke[J]. FEBS Lett, 2024, 598(17): 2160-2173. doi: 10.1002/1873-3468.14894
|
| [26] |
YE Y, XIE X, BI Y, et al. Naoqing formula alleviates acute ischaemic stroke-induced ferroptosis via activating Nrf2/xCT/GPX4 pathway[J]. Front Pharmacol, 2024, 15: 1525456. DOI: 10.3389/fphar.2024.1525456.
|
| [27] |
ZHAO Y, LIU Y, XU Y, et al. The role of ferroptosis in blood-brain barrier injury[J]. Cell Mol Neurobiol, 2023, 43(1): 223-236. doi: 10.1007/s10571-022-01197-5
|
| [28] |
ZHAO Y, YANG M, LIANG X. The role of mitochondria in iron overload-induced damage[J]. J Transl Med, 2024, 22(1): 1057. DOI: 10.1186/s12967-024-05740-4.
|
| [29] |
NADGAUDA K P, METGUD D C, BELLAD R M, et al. Exploring the association between haematological markers of iron and general movements in 4-month-old infants exposed to anaemia in-utero[J]. Early Hum Dev, 2024, 195: 106080. DOI: 10.1016/j.earlhumdev.2024.106080.
|
| [30] |
MAIO N, SANETO R P, STEET R, et al. Disruption of cellular iron homeostasis by IREB2 missense variants causes severe neurodevelopmental delay, dystonia and seizures[J]. Brain Commun, 2022, 4(3): fcac102. DOI: 10.1093/braincomms/fcac102.
|